Codes / ICD10CM / T48.1X3A

T48.1X3A Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter

Summary

This condition involves poisoning by neuromuscular blocking agents, a class of skeletal muscle relaxants, resulting from an assault. It occurs when exposure to these drugs is intentional and non-self-inflicted, leading to clinical effects such as neuromuscular or respiratory impairment. The scenario reflects an external act of harm, typically requiring immediate medical intervention.

Causes

Assault-related poisoning results from deliberate exposure to neuromuscular blocking agents by another individual. This may involve forced administration, intentional dosing errors, or contamination of substances with these medications. Access to neuromuscular blockers in medical or non-medical settings can facilitate such exposures.

Risk Factors

  • Proximity to or access to neuromuscular blocking agents (e.g., in healthcare, home, or public environments).
  • Situations involving interpersonal conflict or violence.
  • Vulnerable populations at risk of assault (e.g., due to social, environmental, or personal factors).
  • Concurrent use of other drugs that may influence susceptibility to poisoning.

Symptoms

  • Muscle weakness or paralysis (skeletal or respiratory).
  • Respiratory depression or difficulty breathing.
  • Dizziness, confusion, or altered mental status.
  • Nausea, vomiting, or gastrointestinal distress.
  • Hypotension or cardiovascular instability.

Diagnosis

Clinical evaluation focuses on symptom correlation with potential exposure to neuromuscular blocking agents and confirmation of assault. History-taking, physical examination, and toxicology screening may be used to identify the cause. Documentation of the assault context is critical for accurate diagnosis and coding.

Treatment Options

Treatment involves immediate stabilization, including airway management, respiratory support, and cardiovascular monitoring. Antidotes (e.g., acetylcholinesterase inhibitors) may be administered if appropriate. Supportive care, such as mechanical ventilation or vasopressors, addresses complications. Psychiatric or social services may be involved if the assault is linked to broader safety concerns.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of intervention, and severity of symptoms. Early treatment improves outcomes, but residual neuromuscular or respiratory effects may persist. Follow-up includes monitoring for delayed complications and addressing any underlying trauma or safety issues related to the assault.

Complications

  • Respiratory failure requiring prolonged mechanical ventilation.
  • Prolonged muscle weakness or paralysis.
  • Cardiovascular instability (e.g., hypotension, arrhythmias).
  • Neurological sequelae (e.g., confusion, cognitive impairment).
  • Psychological trauma or PTSD related to the assault.

Lifestyle & Prevention

Prevention focuses on reducing access to neuromuscular blocking agents in non-medical settings and addressing interpersonal violence. Secure storage of medications, education on drug safety, and support for at-risk individuals may mitigate risks. For healthcare settings, strict protocols for medication handling and patient safety are essential.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning (e.g., muscle weakness, difficulty breathing) occur after suspected exposure, especially in the context of an assault. Emergency care is critical to prevent life-threatening complications. Report the assault to appropriate authorities if safety concerns exist.

Tips for Medical Coders

Document the assault context clearly, including the intent (non-self-inflicted) and initial encounter status. Ensure the code T48.1X3A is used for initial encounters of assault-related poisoning by neuromuscular blocking agents. Verify that the "initial encounter" modifier is appropriate and that no other codes (e.g., for injuries) are omitted if relevant.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T48.1X3A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.